International Arbitration of Life Sciences Disputes: Key Issues and Best Practices
Presented by International Court of Arbitration (ICC)
About the EventThe life sciences industry - pharmaceuticals, medical devices, diagnostics, vaccines and related businesses - is huge, growing and global, with international licensing, sales contracts, research and development agreements, and joint ventures. Each of these international ventures can lead to disputes, and well-positioned life sciences companies prefer international arbitration to litigation as the practical way to achieve confidential, widely enforceable judgments in a neutral setting. Listen in as our distinguished panel of speakers explain why international arbitration is the preferred dispute resolution mechanism for life sciences disputes, before they take a deeper dive into some of the complex issues that can arise in such disputes. Then join us for a reception following the event Featured JAMS SpeakerConna A. Weiner, Esq. |
|
Date / TimeWednesday, April 10, 2019 |
LocationCharles River Associates |
Featured People
- Business Commercial
- Employment Law
- Health Care
- Intellectual Property
- International & Cross-Border
- Life Sciences
- Pharmaceuticals & Mass Torts